Stock Scorecard
Stock Summary for Axogen Inc (AXGN) - $18.99 as of 3/28/2025 7:17:32 PM EST
Total Score
7 out of 30
Safety Score
38 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AXGN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AXGN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AXGN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AXGN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for AXGN (38 out of 100)
Stock Price Rating (Max of 10) | 6 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 3 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 4 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 1 |
Trading Volume (Max of 10) | 6 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AXGN
Financial Details for AXGN
Company Overview |
|
---|---|
Ticker | AXGN |
Company Name | Axogen Inc |
Country | USA |
Description | AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | 4/30/2025 |
Stock Price History |
|
Last Day Price | 18.99 |
Price 4 Years Ago | 9.37 |
Last Day Price Updated | 3/28/2025 7:17:32 PM EST |
Last Day Volume | 657,659 |
Average Daily Volume | 600,630 |
52-Week High | 21.00 |
52-Week Low | 5.55 |
Last Price to 52 Week Low | 242.16% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 25.03 |
Sector PE | 40.10 |
5-Year Average PE | -3.82 |
Free Cash Flow Ratio | 34.53 |
Industry Free Cash Flow Ratio | 16.96 |
Sector Free Cash Flow Ratio | 47.05 |
Current Ratio Most Recent Quarter | 3.74 |
Total Cash Per Share | 0.55 |
Book Value Per Share Most Recent Quarter | 2.35 |
Price to Book Ratio | 8.10 |
Industry Price to Book Ratio | 3.00 |
Sector Price to Book Ratio | 21.92 |
Price to Sales Ratio Twelve Trailing Months | 4.50 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.90 |
Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
Analyst Buy Ratings | 4 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 44,343,800 |
Market Capitalization | 842,088,762 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 1/27/2010 |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 1.0000 |
Total Years Dividend Increasing | 0 |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 16.67 |
Forward Annual Dividend Yield | 106.56% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 1,566.67% |
3-Year Dividend Growth Rate Percentage | 1,566.67% |
5-Year Dividend Growth Rate Percentage | 1,566.67% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 24.98% |
Reported EPS 12 Trailing Months | -0.23 |
Reported EPS Past Year | 0.13 |
Reported EPS Prior Year | -0.18 |
Net Income Twelve Trailing Months | -14,307,000 |
Net Income Past Year | -21,716,000 |
Net Income Prior Year | -28,948,000 |
Quarterly Revenue Growth YOY | 15.10% |
5-Year Revenue Growth | 13.63% |
Operating Margin Twelve Trailing Months | 4.08% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 24,530,000 |
Total Cash Past Year | 31,024,000 |
Total Cash Prior Year | 48,789,000 |
Net Cash Position Most Recent Quarter | -22,742,000 |
Net Cash Position Past Year | -15,579,000 |
Long Term Debt Past Year | 46,603,000 |
Long Term Debt Prior Year | 45,712,000 |
Total Debt Most Recent Quarter | 47,272,000 |
Equity to Debt Ratio Past Year | 0.67 |
Equity to Debt Ratio Most Recent Quarter | 0.68 |
Total Stockholder Equity Past Year | 95,665,000 |
Total Stockholder Equity Prior Year | 100,999,000 |
Total Stockholder Equity Most Recent Quarter | 99,407,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -9,899,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.22 |
Free Cash Flow Past Year | -20,634,000 |
Free Cash Flow Prior Year | -37,319,000 |
Options |
|
Put/Call Ratio | 3.33 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.11 |
MACD Signal | -0.01 |
20-Day Bollinger Lower Band | 12.82 |
20-Day Bollinger Middle Band | 16.78 |
20-Day Bollinger Upper Band | 20.75 |
Beta | 1.02 |
RSI | 57.20 |
50-Day SMA | 12.49 |
150-Day SMA | 10.00 |
200-Day SMA | 10.77 |
System |
|
Modified | 3/28/2025 6:29:29 PM EST |